Pre-Commercial Mover: Addex Therapeutics Ltd
Addex Therapeutics Ltd – ADR (ADXN) fell on Friday morning, with the stock falling -3.76% in premarket trading to 1.28. ADXN’s short-term technical score of 1 indicates that the stock has traded less bullishly over the past month than 99% of stocks in the market. In the biotech industry, which ranks 119th out of 146 industries, Addex Therapeutics Ltd – ADR ranks above 3% of the stock. Addex Therapeutics Ltd – ADR has risen 43.01% over the past month, closing at $1.98 on July 22. During this period, the stock fell to $1.09 and $2.19. ADXN has an average analyst recommendation of Sell.
Addex Therapeutics Ltd – ADR has a long-term technical rating of 0. This means that trading over the past 200 trading days has placed the company in the bottom half of the stock, with 100% of the market scoring higher. In the biotech industry which is number 83 by this metric, ADXN ranks better than 83% of stocks.
Important dates for investors in ADXN:
-Addex Therapeutics Ltd – ADR is expected to report earnings on 16/11/2022 -We do not have a fixed dividend date for Addex Therapeutics Ltd – ADR at this time. Click here for the full report on Addex Therapeutics Ltd – ADR (ADXN)
Stay in the know
Subscribe to our daily morning update newsletter and never miss market news, moves and more.